CME 
JOBS 
OUTBREAKS 
PEER-TO-PEER 
QUIZZES & QUESTIONS 
MEDTECH The CGM is designed to help patients optimize their nutrition and exercise routines without the interruption of unnecessary alerts.
Dexcom is set to introduce a novel continuous glucose monitor (CGM) specifically designed for the 25 million non-insulin-using Americans with type 2 diabetes. This strategic move targets a significant unmet need in this patient group, offering tailored solutions to help them understand the lifestyle effects on blood glucose levels and aid in the prevention of insulin use.
Key Points:
- The CGM, a modification of the Dexcom G7, is slated to have a 15-day lifespan and will include a cash-pay option.
- The CGM comes with software designed to help patients understand the impact of their lifestyle choices on blood glucose levels, with the intention of delaying or preventing the need for insulin.
- Dexcom’s analysis identified a significant unmet need for CGM use in this population, with fewer than 5% currently utilizing such technology.
Additional Points:
- Dexcom plans to address the needs of this patient population through digital health partnerships, pursuing reimbursements, and building a software package customized for their needs.
- Exact details on the device’s feature set and pricing are currently withheld due to confidentiality reasons, but it is indicated that current market products do not fully meet the needs of this population.
Conclusion:
- Dexcom’s move to introduce a CGM tailored for non-insulin-using type 2 diabetes patients is a strategic approach to address the significant gaps in continuous glucose monitoring within this patient population.
Endocrinology Latest Points
- 9 Health Benefits of Cashews
- Once-Weekly Semaglutide in Persons with Obesity and Knee Osteoarthritis
- Off-brand Ozempic Leaves 10 Dead, 100 Hospitalized
- Comparative Effectiveness and Safety of Atorvastatin Versus Rosuvastatin: A Multi-database Cohort Study
“These customers want personal insights to optimize their nutrition and exercise routines, and they want those insights without the burden of unnecessary alarms and alerts throughout the day.”
Teri Lawver
Chief Commercial Officer
Dexcom
